ASK1 associates with troponin T and induces troponin T phosphorylation and contractile dysfunction in cardiomyocytes

American Journal of Pathology

Volumn 163, Issue 1, 2003, Pages 243-251

  He, Xiangrong ^a   Liu, Yingmei ^a   Sharma, Virendra ^a   Dirksen, Robert T ^a   Waugh, Richard ^a   Sheu, Shey Shing ^a   Min, Wang ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; INTERLEUKIN 1; PHOSPHOTRANSFERASE; REACTIVE OXYGEN METABOLITE; TROPONIN T; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CARBOXY TERMINAL SEQUENCE; CARDIOMYOPATHY; CONTROLLED STUDY; DNA ISOLATION; DNA LIBRARY; ENZYME ACTIVATION; ENZYME SUBSTRATE; GENE OVEREXPRESSION; HEART DISEASE; HEART FAILURE; HEART MUSCLE CONTRACTILITY; MEDIATOR RELEASE; MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0037969707     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63647-4     Document Type: Article

References (43)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990, 323:236-241
2. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S: Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994, 72:561-566
3. McMurray J, Abdullah I, Dargie HJ, Shapiro D: Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure. Br Heart J 1991, 66:356-358
4. Dhalla AK, Hill MF, Singal PK: Role of oxidative stress in transition of hypertrophy to heart failure. J Am Coll Cardiol 1996, 28:506-514
5. Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY, McTiernan C: The role of tumor necrosis factor in the pathophysiology of heart failure. J Am Coll Cardiol 2000, 35:537-544
6. Grandel U, Fink L, Blum A, Heep M, Buerke M, Kraemer HJ, Mayer K, Bohle RM, Seeger W, Grimminger F, Sibelius U: Endotoxin-induced myocardial tumor necrosis factor-alpha synthesis depresses contractility of isolated rat hearts: evidence for a role of sphingosine and cyclooxygenase-2-derived thromboxane production. Circulation 2000, 102:2758-2764
7. Mann DL: Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002, 91:988-998
8. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992, 257:387-389
9. Gulick T, Chung MK, Pieper SJ, Lange LG, Schreiner GF: Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 1989, 86:6753-6757
10. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL: Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest 1993, 92: 2303-2312
11. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997, 81:627-635
12. Ip YT, Davis RJ: Signal transduction by the c-Jun N-terminal kinase (JNK) - from inflammation to development. Curr Opin Cell Biol 1998, 10:205-219
13. Ichijo H: From receptors to stress-activated MAP kinases. Oncogene 1999, 18:6087-6093
14. Alpert NR, Mulieri LA, Litten RZ, Holubarsch C: A myothermal analysis of the myosin crossbridge cycling rate during isometric tetanus in normal and hypothyroid rat hearts. Eur Heart J 1984, 5(Suppl F):3-11
15. Pagani ED, Alousi AA, Grant AM, Older TM, Dziuban Jr SW, Allen PD: Changes in myofibrillar content and Mg-ATPase activity in ventricular tissues from patients with heart failure caused by coronary artery disease, cardiomyopathy, or mitral valve insufficiency. Circ Res 1988, 63:380-385
16. Filatov VL, Katrukha AG, Bulargina TV, Gusev NB: Troponin: structure, properties, and mechanism of functioning. Biochemistry (Mosc) 1999, 64:969-985
17. Seidman JG, Seidman C: The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms. Cell 2001, 104: 557-567
18. Takeishi Y, Chu G, Kirkpatrick DM, Li Z, Wakasaki H, Kranias EG, King GL, Walsh RA: In vivo phosphorylation of cardiac troponin I by protein kinase Cbeta2 decreases cardiomyocyte calcium responsiveness and contractility in transgenic mouse hearts. J Clin Invest 1998, 102:72-78
19. Noland Jr TA, Kuo JF: Protein kinase C phosphorylation of cardiac troponin I and troponin T inhibits Ca(2+)-stimulated MgATPase activity in reconstituted actomyosin and isolated myofibrils, and decreases actin-myosin interactions. J Mol Cell Cardiol 1993, 25:53-65
20. Venema RC, Kuo JF: Protein kinase C-mediated phosphorylation of troponin I and C-protein in isolated myocardial cells is associated with inhibition of myofibrillar actomyosin MgATPase. J Biol Chem 1993, 268:2705-2711
21. Zhang R, Zhao J, Potter JD: Phosphorylation of both serine residues in cardiac troponin I is required to decrease the Ca affinity of cardiac troponin C. J Biol Chem 1995, 270:30773-30780
22. Ichijo H, Nishida E, Irie K, ten D-P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997, 275:90-94
23. Tobiume K, Matsuzawa A, Takahashi T, Nishitoh H, Morita K, Takeda K, Minowa O, Miyazono K, Noda T, Ichijo H: ASK1 is required for sustained activations of JNK/p38 MAP kinases and apoptosis. EMBO Rep 2001, 2:222-228
24. Gotoh Y, Cooper JA: Reactive oxygen species- and dimerization-induced activation of apoptosis signal-regulating kinase 1 in tumor necrosis factor-alpha signal transduction. J Biol Chem 1998, 273: 17477-17482
25. Saitoh M, Nishitoh H, Fujii M, Takeda K, Tobiume K, Sawada Y, Kawabata M, Miyazono K, Ichijo H: Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998, 17:2596-2606
26. Zhang L, Chen J, Fu H: Suppression of apoptosis signal-regulating kinase 1-induced cell death by 14-3-3 proteins. Proc Natl Acad Sci USA 1999, 96:8511-8515
27. Liu H, Nishitoh H, Ichijo H, Kyriakis JM: Activation of apoptosis signal-regulating kinase 1 (ASK1) by tumor necrosis factor receptor-associated factor 2 requires prior dissociation of the ASK1 inhibitor thioredoxin. Mol Cell Biol 2000, 20:2198-2208
28. Liu Y, Yin G, Surapisitchat J, Berk BC, Min W: Laminar flow inhibits TNF-induced ASK1 activation by preventing dissociation of ASK1 from its inhibitor 14-3-3. J Clin Invest 2001, 107:917-923
29. Liu Y, Min W: Thioredoxin promotes ASK1 ubiquitination and degradation to inhibit ASK1-mediated apoptosis in a redox activity-independent manner. Circ Res 2002, 90:1259-1266
30. Tobiume K, Inage T, Takeda K, Enomoto S, Miyazono K, Ichijo H: Molecular cloning and characterization of the mouse apoptosis signal-regulating kinase 1. Biochem Biophys Res Commun 1997, 239: 905-910
31. Sheu SS, Sharma VK, Banerjee SP: Measurement of cytosolic free calcium concentration in isolated rat ventricular myocytes with quin 2. Circ Res 1984, 55:830-834
32. Naldini L, Blomer U, Gallay P, Cry D, Mulligan R, Gage FH, Verma IM, Trono D: In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267
33. Yin G, An P, Li P, Ding I, Schwarz EM, Min W: Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol Ther 2002, 5:547-554
34. Sharma VK, Colecraft HM, Wang DX, Levey AI, Grigorenko EV, Yeh HH, Sheu SS: Molecular and functional identification of ml muscarinic acetylcholine receptors in rat ventricular myocytes. Circ Res 1996, 79:86-93
35. Avilaa G, O'Brien JJ, Dirksen RT: Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc Natl Acad Sci USA 2001, 98:4215-4220
36. Yuasa K, Michibata H, Omori K, Yanaka N: A novel interaction of cGMP-dependent protein kinase I with troponin T. J Biol Chem 1999, 274:37429-37434
37. Zou X, Tsutsui T, Ray D, Blomquist JF, Ichijo H, Ucker DS, Kiyokawa H: The cell cycle-regulatory CDC25A phosphatase inhibits apoptosis signal-regulating kinase 1. Mol Cell Biol 2001, 21:4818-4828
38. Saggin L, Ausoni S, Gorza L, Sartore S, Schiaffino S: Troponin T switching in the developing rat heart. J Biol Chem 1988, 263:18488-18492
39. Montgomery DE, Chandra M, Huang Q, Jin J, Solaro RJ: Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. Am J Physiol 2001, 280:H1011-H1018
40. Petrich BG, Gong X, Lerner DL, Wang X, Brown JH, Saffitz JE, Wang Y: c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes. Circ Res 2002, 91:640-647
41. Zhang D, Gaussin V, Taffet GE, Belaguli NS, Yamada M, Schwartz RJ, Michael LH, Overbeek PA, Schneider MD: TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice. Nat Med 2000, 6:556-563
42. Bishopric NH, Webster KA: Preventing apoptosis with thioredoxin ASK me how. Circ Res 2002, 90:1237-1239
43. Hirotani S, Otsu K, Nishida K, Higuchi Y, Morita T, Nakayama H, Yamaguchi O, Mano T, Matsumura Y, Ueno H, Tada M, Hori M: Involvement of nuclear factor-kappaB and apoptosis signal-regulating kinase 1 in G-protein-coupled receptor agonist-induced cardiomyocyte hypertrophy. Circulation 2002, 105:509-515